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INTRODUCTION
As a consequence of  the amplified need for better 
connection of  health‑care costs with quality of  care given, 
outcome parameters linked to patients’ overall health status 
are gaining a significance equal to or greater than studies 
based on symptoms or biologic and physiologic variables.1‑3 
In particular, health‑related quality‑of‑life (HR‑QoL) results 
have become crucial factors in the growth and refinement 
of  practice‑guiding principle, the assessment of  patterns of  
medical care and the analysis of  therapeutic interventions. 
Allergic rhinitis (AR) is a symptom complex of  consisting 
of  nasal congestion, rhinorrhoea, sneezing and nasal 
itching arising from an IgE‑mediated allergic reaction 
and inflammation of  the mucosal lining of  the nose and 
contiguous mucosal membranes usually due to airborne 
allergen. AR may occur in isolation or may coexist with 
allergic conjunctivitis (AC). The simultaneous existence is 
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Background: Allergic rhinitis (AR) is a symptom complex of consisting of nasal congestion, rhinorrhoea, 
sneezing and nasal itching arising from an IgE-mediated allergic reaction and inflammation of the mucosal 
lining of the nose and contiguous mucosal membranes usually due to airborne allergen. AR may occur in 
isolation or may coexist with allergic conjunctivitis (AC).
Aim: The aim of this study is to assess and evaluate the importance of health-related quality of life (HR-QoL) 
in patients suffering from concomitant AC with AR with different types of quality-of-life instruments.
Methods: A sum of 220 patients who attended the outpatient department of ENT clinic were involved in 
this study. All patients undertook an ophthalmologic examination for coexistent AC. The rhino conjunctivitis 
quality of life questionnaire (RQLQ) was used to evaluate the quality of life in all patients.
Results: The mean age of the 220 patients (116 females and 104 males) involved in the study was 26.8 years. 
The male-to-female ratio was 1:1.1. Of the 220 patients, 55% studied up to secondary school graduation 
and 18% dwelt in the rural area. In the assessment of the statistics obtained from the AR and conjunctivitis 
symptom scoring, the mean total complaint score was found to be 13.2 ± 4.0.
Conclusion: AR can vary based on a region’s flora, weather and socioeconomic status. AR could lead to 
severe impairment in HR-QoL.
Keywords: Allergic conjunctivitis, allergic rhinitis, health-related quality of life
Abstract
Aremu, et al.: Burden of allergic rhinitis and allergic conjunctivitis
Port Harcourt Medical Journal | Volume 12 | Issue 3 | September-December  2018 143
really worrisome in patients and may significantly affect 
the quality of  life of  such patients.
The frequent coexistence of  AR and AC means that the 
presence and severity of  AC should be assessed in every 
patient with AR. Furthermore, adequate management of  both 
diseases is essential to achieve optimal therapeutic outcomes.
In this study, we aimed to assess and evaluate the importance 
of  HR‑QoL in patients suffering from concomitant AC 
with AR with different types of  quality‑of‑life instruments.
METHODOLOGY
This is a prospective study carried out between March 
2017 and February 2018, involving 220 patients who 
attended the Outpatient Department of  the ENT Clinic 
of  Federal Teaching Hospital Ido‑Ekiti. Ethics were 
approved by the Ethical Committee of  our institution. 
Written and informed consent was taken for all the patients. 
A structured questionnaire was used to obtained relevant 
information from the patients. All patients undertook 
ophthalmologic examination for coexistent AC. The data 
were analysed using the Statistical Package for the Social 
Sciences (SPSS) version 22.0 (IBM Corp., Armonk, New 
York,USA). P < 0.05 was considered statistically significant. 
Average, median, mode, standard deviation, minimum–
maximum and ratio values were used for expressive analysis 
of  the data. The distribution of  variables was measured 
with the Kolmogorov–Smirnov test. Paired t‑test was 
employed for studying quantitative values. Chi‑square 
test was taken into consideration for analysing qualitative 
values. For the scrutiny of  correlation, Pearson/Spearman 
correlation analysis coefficient was employed. Statistical 
values of  patients were noted in terms of  age, sex, smoking, 
educational qualification, an area of  dwelling, type of  illness 
and time period of  complaints.
For assessing the HR‑QoL in patients with AR, the 
rhinoconjunctivitis quality‑of‑life scale (RQLQ), which 
consisted of  28 questions under seven main headings (sleep, 
non‑hay fever complaints, practical issues, nasal complaints, 
ophthalmic complaints, activities and emotionality), was 
used. All patients were asked to answer the questions 
between 0 – ‘not disturbed’ and 6 – ‘too much disturbed’. 
Furthermore, three day‑to‑day activity limitations due to 
the illness were documented.
The diagnosis of  AR was made through history, anterior 
rhinoscopy and endoscopic nasal inspection and with three 
and more positive (+++) reactions to at least one allergen in 
the skin prick test. Skin prick examination was executed on 
the interior surface of  the forearm with the help of  a test 
panel, comprising standard allergens (Stallergenes, Antony 
Cedex, France). Saline was taken as a negative control, and 
histamine was taken as a positive control.
An eye examination was sought for all the patients, and the 
occurrence of  associated AC was noted. The diagnosis of  AC 
was established for patients who had eye symptoms and who 
presented with signs of  conjunctival congestion, oedema, 
eyelid oedema and/or papillary reaction on inspection. 
Furthermore, all patients went through AR and conjunctivitis 
complaint scoring, including seven parameters (four nasal and 
three eye parameters), which were excessive nasal secretion, 
nasal itch, nasal obstruction, excessive sneezing, burning or 
itchy eyes, eye redness and watery eyes. They were requested 
to score the items between 0 and 3 (0 – no complaint, 
1 – mild [feeling a little], 2 – moderate [feeling during daytime] 
and 3 – severe [feeling as much as it affects daily life]).
Patients who were on antihistaminic, anti‑inflammatory, 
topical or systemic steroid, immunosuppressive, 
antidepressant or antihypertensive medications within 
the previous 20 days were excluded from the research. 
Furthermore, patients with nasal pathologies, such 
as chronic sinusitis, nasal septum deviation, turbinate 
hypertrophy and nasal polyposis, except for AR, and with 
concurrent systemic ailments were also ruled out.
RESULTS
The mean age of  the 220 patients(116 females and 
104males) involved in the study was 26.8 years. The 
maletofemale ratio was 1:1.1. Of  the 220 patients, 55% 
studied up to secondary school graduation and 18% 
dwelled in the rural area. The mean time for symptoms was 
found to be 4.8 years. The patients’ age, gender, smoking 
history, education status, residence area and AR type are 
shown in Figure 1.
Figure 1: Sociodemographic data
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In the assessment of  the statistics obtained from the 
AR and conjunctivitis symptom scoring, the mean total 
complaint score was found to be 13.2 ± 4.0. When RQLQ 
scores were evaluated, it was detected that the scores under 
the title of  practical concerns were greater [Table 1].
The RQLQ scoring system used in this study is shown in 
Table 2. In the assessment of  the 220 patients’ restricted 
activities, 15 activities that influenced the daily lives of  the 
patients due to illness were identified from 295 responses. 
The frequently affected daily activities were talking in a 
community, sleeping, eating and school life. The activity 
for which patients complained more severely due to 
illness was found to be school life and studying [Table 3]. 
Nasal symptom score, ocular symptom score and total 
symptom score were higher in the group with coexistent 
AC than in the group without AC (P < 0.05). In the group 
with coexistent AC, RQLQ scores of  sleep, nonhay fever 
complaints, nasal complaints, ophthalmic complaints and 
restricted activities were significantly higher compared 
to the group without AC [Figure 2; P < 0.05]. In terms 
of  the relationship between symptom scores and RQLQ 
scores, a positive significant correlation was found between 
the scores of  nasal symptom, ocular symptom and total 
symptom and the RQLQ scores of  sleep, nonhay fever 
complaint, nasal complaint, ophthalmic complaint and 
restricted activities using Pearson/Spearman correlation 
(P < 0.05).
DISCUSSION
Although not a life‑threatening condition, AR has a 
prevalence of  ≥10% of  the entire populace all over the 
world with a noteworthy social influence and should not 
be left to its natural progression.4 Its the natural history 
Figure 2: Comparison of groups with and without coexistent allergic 
conjunctivitis
Table 2: Quality‑of‑life parameters measured by the 
rhinoconjunctivitis quality‑of‑life scale questionnaire
Dimension
Sleep
Lack of a good night’s sleep
Wake up during the night
Difficulty getting to sleep
Non‑hay fever symptoms
Tiredness
Fatigue
Worn out
Reduced productivity
Poor concentration
Thirst
Headache
Practical problems
Need to blow nose repeatedly
Need to rub nose/eyes
Inconvenience of having to carry tissues 
or handkerchief
Nasal symptoms
Stuffy/blocked
Sneezing
Runny
Itchy
Eye symptoms
Itchy
Watery
Swollen
Sore
Emotions
Irritable
Frustrated
Impatient or restless
Embarrassed by nose/eye symptoms
Activities
Talking in a community
Sleep
Eating
School life
Working life
Reading book
House cleaning
Shopping
Studying
Driving
Childcare
Traveling
Worship
Sports
Washing up
Table 1: Data obtained from allergic rhinitis and 
conjunctivitis symptom scoring and rhinoconjunctivitis 
quality‑of‑life scale
Mean±SD
AR and conjunctivitis symptom scoring
Nasal symptom score 9.1±1.2
Ocular symptom score 4.1±2.8
Total symptom score 13.2±4.0
RQLQ scoring
Sleep 3.1±1.6
Non‑hay fever complaints 3.4±0.9
Practical issues 4.2±0.8
Nasal complaints 3.8±0.8
Ophthalmic complaints 2.0±1.3
Restricted activities 3.9±0.8
Emotionality 3.1±0.5
SD: Standard deviation, RQLQ: Rhinoconjunctivitis quality‑of‑life scale, 
AR: Allergic rhinitis
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that begins with the convention between the atopic person 
and allergenic substances is distinct, during the early years 
of  allergic illness, by typical indicators: pale nasal mucosa, 
oedema of  middle and lower turbinates, increased watery 
secretion (rhinorrhoea), itching, sneezing and nasal 
congestion.4 When an allergen that comes in the body 
through inhalation approaches mast cells, it leads to the 
release of  many inflammatory mediators through IgE. 
These inflammatory mediators such as interleukin‑1 and 
tumour necrosis factor‑alpha increase vascular permeability 
and lead to watery nasal secretion and oedema in the nasal 
cavity, nasal congestion and increased mucous secretion. 
Moreover, allergen‑sensitive nerve endings are stimulated 
resulting to and nasal itching and sneezing.5
The association amid AR and other allergic diseases, such 
as AC, has been testified.6‑8 In Europe, nearly 71% of  AR 
patients have both nasal and ophthalmic symptoms. AR 
outcomes with accompanying ophthalmic outcomes affect 
patients’ HR‑QoL in an undesirable way and make their 
day‑to‑day performance inferior.7
Intranasal corticosteroids (INSs) have been shown to reduce 
the ophthalmic as well as nasal symptoms in association with 
AR and AC.9‑11 Likewise, non‑sedating antihistamines are 
effective at controlling ocular complaints of  AR patients.12 
Other similar studies indicate that intranasal corticosteroids 
offer equal or more relief  of  ophthalmic allergy complaints 
as compared to intranasal or oral antihistamines.13 Although, 
antihistamines usually have their highest effectiveness in 
the early stage, histamine‑mediated symptoms (e.g., itching 
and rhinorrhoea) and reduced usefulness in treating 
late‑stage symptoms (e.g., congestion).10 Latest patients’ 
preference research studies have shown that patients’ have 
high expectations of  their antiallergic medications, with 
expectations such as complete symptom relief, quick‑onset 
and long‑lasting effects and favourable or no adverse 
effects.14,15 On the other hand, patients are often unhappy 
with the efficiency of  their medications which can cause 
poor patient compliance and addition of  over‑the‑counter 
products.15 A research study of  patients under expert care 
stated that patients favoured nasal spray as compared to 
oral treatment; however, feared adverse events (such as 
habituation, injury to mucous membranes, dependence and 
effect on other organs) of  INS therapies are still present.14 
Thus, this highlights the necessity of  INS treatments to 
have good all round efficacy, with a reassuring safety profile, 
to provide a complete treatment for AR that improves the 
patients’ HR‑QoL.
AR is a long‑lasting illness that is reasonably common 
around the world and leads to a substantial reduction 
in HR‑QoL. Since epidemiological data, humidity rate, 
vegetation and allergens differ in countries and even in 
regions of  a country, regional studies are important for 
analysing the disease with accurate data. The ratio of  AR 
was found to be 11.4% in Aydın in the study of  Başak 
et al.,16 while it was 30% in Eskişehir in the study of  Cingi 
et al.17 This research and other comparable ones in the 
literature offer evidence for the fact that the values for 
AR patients and the incidence of  the illness may differ 
depending on the areas.
The frequency of  AR is greater in people living in urban 
centres than in peoples inhabiting in rural regions. In the 
study piloted by Topal et al.,18 it was described that 66.2% 
of  the patients in the area of  Konya lived in the city centre. 
In our case, only 18% of  patients lived in rural areas.
The coexistence of  AC is well‑recognised in patients with 
AR.10,19‑25 Although coreporting frequency may be as low as 
40%. Underrecognition of  AC may be due to patients and 
physicians paying more attention to allergic comorbidities 
such as AR or rhinitis or the underappreciation of  the 
variability of  eye symptoms in patients with AC.26‑28
Juniper et al.29 established an association amid daily practical 
problems and AR problems in their work. Furthermore, 
in other similar studies in the literature, a mild‑moderate 
correlation was seen amongst the severity of  AR symptom 
and the HR‑QoL.30 Since RQLQ is more of  a problem and 
symptom‑based questionnaire, the existence of  a correlation 
with symptom score is a predictable result. In our study, a 
similar correlation was found with symptom score.
The major limitation of  the study is that it did not involve 
participants from the general population but instead focused 
on patients who were referred to ENT outpatient clinic.
Table 3: Distribution of restricted activities and symptom 
scores
Restricted activities n Mean symptom score
Talking in a community 117 4.3±1.2
Sleep 71 3.8±1.2
Eating 67 4.0±1.1
School life 65 4.8±0.9
Working life 46 4.3±1.3
Reading book 46 3.5±0.9
House cleaning 44 3.2±1.0
Shopping 8 3.6±1.1
Studying 9 4.8±0.9
Driving 39 3.5±1.3
Childcare 35 3.4±1.0
Traveling 11 2.6±0.5
Worship 12 3.5±0.8
Sports 7 4.1±0.6
Washing up 2 4.6±0.2
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CONCLUSION
AR can vary based on a region’s flora, weather and 
socioeconomic status. We assessed the sociogeographic 
features of  patients with comorbid AC and their HR‑QoL, 
and we perceived that AR could lead to severe impairment in 
HR‑QoL. The information acquired in our research should 
be reinforced with more widespread studies. The fact that 
this chronic disease can impair, the patients’ quality of  life 
should be taken into consideration. Patients should be assessed 
in collaboration with a psychiatry clinic when required. In 
deduction, although AR patients often come to the ENT clinic, 
it should be kept in mind that a multidisciplinary approach is 
desirable for the diagnosis and treatment of  the illness.
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